We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

105 hedge funds and large institutions have $136M invested in VanEck Biotech ETF in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $355K

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

11% more capital invested

Capital invested by funds: $123M → $136M (+$13.4M)

2.41% more ownership

Funds ownership: 25.65% → 28.06% (+2.4%)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

3% less funds holding

Funds holding: 108 → 105 (-3)

Holders
105
Holders Change
-3
Holders Change %
-2.78%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
30
Reduced
26
Closed
9
Calls
$1.37M
Puts
$355K
Net Calls
+$1.01M
Net Calls Change
+$1.25M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$9.04M
2
FP
Financial Perspectives
Minnesota
+$2.78M
3
FFN
Focus Financial Network
Minnesota
+$2.52M
4
HighTower Advisors
HighTower Advisors
Illinois
+$1.91M
5
GT
Glenview Trust
Kentucky
+$1.68M

Top Sellers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.8M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.34M
3
Citadel Advisors
Citadel Advisors
Florida
-$976K
4
RJA
Raymond James & Associates
Florida
-$720K
5
HPCM
Hunter Perkins Capital Management
Illinois
-$556K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$21M +$9.04M +50,000 +72%
Morgan Stanley
2
Morgan Stanley
New York
$11.2M -$437K -2,415 -4%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$9.12M -$1.8M -9,942 -16%
KAS
4
Kestra Advisory Services
Texas
$7.38M +$260K +1,440 +4%
UBS Group
5
UBS Group
Switzerland
$7.13M -$434K -2,402 -6%
MCM
6
Murphy Capital Management
New Jersey
$5.96M -$71.6K -396 -1%
Bank of America
7
Bank of America
North Carolina
$5.86M +$317K +1,752 +6%
MJRIC
8
Mogy Joel R Investment Counsel
California
$4.88M +$515K +2,847 +11%
LPL Financial
9
LPL Financial
California
$3.68M +$134K +742 +4%
Stifel Financial
10
Stifel Financial
Missouri
$3.58M +$152K +839 +4%
Citadel Advisors
11
Citadel Advisors
Florida
$3.12M -$976K -5,395 -23%
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$2.83M -$50.6K -280 -2%
FFN
13
Focus Financial Network
Minnesota
$2.77M +$2.52M +13,923 +739%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$2.59M -$1.34M -7,438 -34%
BRC
15
BHF RG Capital
Arizona
$2.47M -$211K -1,166 -8%
BRM
16
Boston Research & Management
Massachusetts
$2.4M -$38K -210 -2%
Rockefeller Capital Management
17
Rockefeller Capital Management
New York
$2M – – –
HighTower Advisors
18
HighTower Advisors
Illinois
$1.85M +$1.91M +10,545 New
CCA
19
Conservest Capital Advisors
Pennsylvania
$1.77M +$23.9K +132 +1%
RJA
20
Raymond James & Associates
Florida
$1.73M -$720K -3,982 -29%
GT
21
Glenview Trust
Kentucky
$1.63M +$1.68M +9,300 New
LFASL
22
Lugano Financial Advisors SA (LFA)
Switzerland
$1.62M +$70.3K +389 +4%
Janney Montgomery Scott
23
Janney Montgomery Scott
Pennsylvania
$1.54M +$22.6K +125 +1%
WANY
24
Wealthspire Advisors (New York)
New York
$1.51M +$234K +1,293 +18%
Envestnet Asset Management
25
Envestnet Asset Management
Illinois
$1.42M +$97.8K +541 +7%
1
2 3 4 5

BBH Hedge Fund Activity: Q1 2021 in Review

105 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2021, worth a combined $136M — up 11% from $123M a quarter earlier.

Fund positioning in BBH was balanced in Q1 2021: 9 funds opened new positions, 9 closed out, 30 added to existing stakes and 26 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.04M. The largest seller was Royal Bank of Canada, cutting an estimated $1.8M.

  • 105 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2021, down from 108 in Q4 2020.
  • Funds reported $136M of VanEck Biotech ETF stock for Q1 2021, up 11% quarter-over-quarter.
  • 9 funds opened new VanEck Biotech ETF positions in Q1 2021 and 9 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2021 was Goldman Sachs, an estimated $9.04M added.
  • The largest VanEck Biotech ETF seller in Q1 2021 was Royal Bank of Canada, an estimated $1.8M sold.

Based on aggregated 13F filings for Q1 2021.